Ose Manager Limited

Active15685130 Private limited company
Incorporated
27 April 2024 (2 years)
Industry
Fund management activities (66300)
Accounts type
Full
Region
South East
Address
46 Woodstock Road
Oxford
OX2 6HT

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
13 May 2027
Last conf. stmt
29 April 2026

Officers 4 active

Officer details are public data from the Companies House register.

Director · Appointed 17 July 2026
British
Born July 1969 (57)
Director · Appointed 31 July 2024
British
Born August 1977 (49)
Director · Appointed 31 July 2024
British
Born October 1967 (59)
Blakeman, Athene Eliana Georgina
Director · Appointed 31 July 2024
British
Born November 1981
Officer history (1 former)
17 July 2026
Appointed Jenkinson, Antonia Scarlett as Director
31 March 2026
Resigned Wilkinson, James Henry as Director
31 July 2024
Appointed Edmondson, Jack Cemlyn as Director
31 July 2024
Appointed Bussey, Edward Martin as Director
31 July 2024
Appointed Blakeman, Athene Eliana Georgina as Director
27 April 2024
Appointed Wilkinson, James Henry as Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Corporate entity · Notified 27 April 2024
Owns 75–100% of shares
Holds 75–100% of voting rights
Public Limited Company
Reg. no. 09093331

Group structure 18 shown

Ownership group derived from the Companies House PSC register

Acionna Therapeutics Ltd Owns 50–75% of shares
Animal Dynamics Limited Owns 50–75% of shares
Archangel Lightworks Ltd Owns 25–50% of shares
Ascension Earth Resources Ltd Owns 25–50% of shares
Caudal Energy Limited Owns 25–50% of shares
Caudal Morlais Limited Owns 75–100% of shares
Circadian Therapeutics Limited Owns 75–100% of shares
Cora Biosciences Limited Owns 25–50% of shares
Credo Therapies Ltd Owns 50–75% of shares
Dark Horse Technologies Ltd In liquidationOwns 25–50% of shares
Densix Limited Owns 25–50% of shares
Dyna Therapeutics Limited Owns 50–75% of shares
Eligentis Limited Owns 25–50% of shares
Enzbond Limited DissolvedOwns 50–75% of shares
Evox Therapeutics Limited Owns 25–50% of shares
Fluorok Limited Owns 25–50% of shares
Ose Manager Limited This company Owns 75–100% of shares

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
16 September 2026Full accounts31 December 2025

Some other companies at this address

Other companies in this industry

By trade and location

New companies in Oxford →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?